About Neurosynaptic
Neurosynaptic is a company based in Bengaluru (India) founded in 2002 by Rajeev Kumar and Sameer Subhash Sawarkar. Neurosynaptic has raised $1.61 million across 6 funding rounds from investors including KOIS, HealthQuad and Axilor Ventures. The company has 30 employees as of March 31, 2024. Neurosynaptic operates in a competitive market with competitors including NuvoAir, MedTel Healthcare, WuXi Diagnostics, Coagulo and Zio Health, among others.
- Headquarter Bengaluru, India
- Employees 30 as on 31 Mar, 2024
- Founders Rajeev Kumar, Sameer Subhash Sawarkar
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Neurosynaptic Communications Private Limited
- Date of Incorporation 20 Sep, 2002
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$1.3 M (USD)38.92as on Mar 31, 2023
-
Net Profit
$50.26 K (USD)109.61as on Mar 31, 2023
-
EBITDA
$304.82 K (USD)70.02as on Mar 31, 2023
-
Total Equity Funding
$1.61 M (USD)
in 6 rounds
-
Latest Funding Round
$118.8 K (USD), Series A
Sep 30, 2020
-
Investors
KOIS
& 58 more
-
Employee Count
30
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Neurosynaptic
Neurosynaptic has successfully raised a total of $1.61M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $118.8 thousand completed in September 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Neurosynaptic
Neurosynaptic has secured backing from 59 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include KOIS, HealthQuad and Axilor Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on acquisitions
|
Locked | Locked | Locked | |
|
Healthcare investment fund focused on innovation and social impact in India.
|
Locked | Locked | Locked | |
|
Angel investor network investing in early-stage startups
|
Locked | Locked | Locked |
Investor details for Neurosynaptic
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Neurosynaptic
Investment portfolio details for Neurosynaptic
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Neurosynaptic
Detailed financials for Neurosynaptic
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neurosynaptic Comparisons
Peer comparison for Neurosynaptic
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Neurosynaptic
Neurosynaptic operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NuvoAir, MedTel Healthcare, WuXi Diagnostics, Coagulo and Zio Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Clinical decision support tools for respiratory diseases are provided.
|
|
| Locked | Locked | Locked |
Remote patient monitoring software is developed for healthcare providers.
|
|
| Locked | Locked | Locked |
Diagnostic solutions for disease identification are offered to healthcare providers.
|
|
| Locked | Locked | Locked |
Precision-medicine platform for blood coagulation disease diagnosis is offered.
|
|
| Locked | Locked | Locked |
Molecular-level home analysis and monitoring for personalized healthcare is offered.
|
Detailed competitors of Neurosynaptic
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neurosynaptic
Complete news archive for Neurosynaptic
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neurosynaptic
Neurosynaptic was founded in 2002 and raised its 1st funding round 4 years after it was founded.
Neurosynaptic is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Sameer Subhash Sawarkar is the current CEO of Neurosynaptic. They have also founded this company.
Neurosynaptic is a funded company, having raised a total of $1.61M across 6 funding rounds to date.
As of Mar 31, 2024, the latest employee count at Neurosynaptic is 30.
Annual revenue of Neurosynaptic is $1.3M as on Mar 31, 2023.
Neurosynaptic is a healthcare technology involved in the development of ICT-based products. The company developing a diagnostic kit - ReMeDi for medical data storage and access and comprising of products such as ECG, stethoscope, temperature measuring, oximeter, etc. The professional edition provides patient and doctor application software which is cloud-based and enables remote consultation. Its enterprise edition comprises of server application along with patient and doctor-client applications offering multiple features. The company claims that its flagship platform, ReMeDi has been deployed in 1600 operational health centers in several developing countries and reaches 50 million people.
Neurosynaptic's top competitors include MedTel Healthcare, WuXi Diagnostics and NuvoAir.
Neurosynaptic has 59 investors. Key investors include KOIS, HealthQuad, Axilor Ventures, Ventureast, and e-Zest.
The valuation of Neurosynaptic is $3.73M as of Sep 2020.